City of Laredo Health Department Announces “Elder Mental Health” Program

Community NewsPublisher's Picks
375

Translate to Spanish or other 102 languages!

The City of Laredo Health Department proudly announces a new program, “Elder Mental Health.” City of Laredo Image

Mega Doctor News

- Advertisement -

Laredo, Texas – Vascular Dementia and Alzheimer’s are two different types of cognitive decline among the elderly population. Causes and treatments for the two spectrums are not the same, and the sooner we identify and treat, the better outcome. 

The City of Laredo Health Department proudly announces a new program, “Elder Mental Health.” The program consists of a group of healthcare specialists from UTSA that include Neuropsychiatrist, Neuropsychologist, and Therapist that will diagnose and provide treatment options to those with cognitive decline.  If you know someone 65 or older with signs of cognitive decline, please emaillcerda@ci.laredo.tx.us or call 956-722-1804 Monday through Friday from 8:00 AM to 5:00 PM. Services are free of charge

CDC Image
City of Laredo Image
- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
FDA Approval of Belzutifan Culminates 25-Year Journey at UTSW From Gene Discovery to A First-In-Class Drug
Next article
Lancet Respiratory Medicine study: Awake prone positioning can prevent intubation in covid-19 patients

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -